Following Its 52-Week Low, Novo Nordisk ADR (NYSE: NVO)’S Share Price Rose 14.7% And Its YTD Numbers Rise 7.35%
During the recent session, Novo Nordisk ADR (NYSE:NVO)’s traded shares were 3.06 million, with the beta value of the company hitting 0.42. At the last